PEDEvidence

SOURCE-LINKED STUDY SUMMARY

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?

Diabetes care ·

Review

What was studied?

Abstract-based narrative review of incretin weight-loss drugs and whether resistance exercise could help preserve lean mass; it did not test a new intervention or comparator.

What changed?

The review reports substantial weight loss with incretin drugs alongside lean-mass loss, and cites resistance-training studies lasting more than 10 weeks that increased lean mass and strength.

Who was studied?

This was a narrative review rather than a newly enrolled cohort; the abstract reports no participant sample size.

Studied exposure

Not extracted or not reported in this source.

What remains uncertain?

No direct trial of resistance exercise during incretin therapy is presented; the exercise recommendation is the authors’ proposal, so preservation during treatment remains untested here.

Abstract summarized · Quality not appraised

Review record & corrections

Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.

No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.

Inspect the source · Correction policy

Save, annotate or compare this study in the library →

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.2337/dci23-0100

Explore related compounds

Evidence and review standards

← All study summaries